GWP
NTLA icon

Gen-Wealth Partners’s Intellia Therapeutics NTLA Stock Holding History

Gen-Wealth Partners’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$605K Buy
47,176
+13,861
+42% +$177K 0.19% 110
2025
Q4 		$299K Buy
33,315
+28,012
+528% +$386K 0.1% 218
2025
Q3 		$91.6K Buy
5,303
+5,262
+12,834% +$64.8K 0.03% 330
2025
Q2 		$385 Hold
41
– – ﹤0.01% 618
2025
Q1 		$292 Hold
41
– – ﹤0.01% 599
2024
Q4 		$478 Hold
41
– – ﹤0.01% 622
2024
Q3 		$588 Hold
41
– – ﹤0.01% 631
2024
Q2 		$918 Hold
41
– – ﹤0.01% 601
2024
Q1 		$1.13K Buy
+41
New +$1.14K ﹤0.01% 580

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return